Consistent with the critical function of AMPK in inhibiting mTOR activity, NSCLC efficiently reduced the intracellular levels of p-S6 and p-AKT in interacting T cells (Fig. 2D, E). This evidence concerns the gene RPS6 and non-small cell lung carcinoma.